Aberrant promoter methylation of cancer-related genes in human breast cancer

The clinical relevance of aberrant DNA methylation is being increasingly recognized in breast cancer. The present study aimed to evaluate the promoter methylation status of seven candidate genes and to explore their potential use as a biomarker for the diagnosis of breast cancer. A total of 70 Chine...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Liang, Shen, Ye, Peng, Xianzhen, Zhang, Simin, Wang, Ming, Xu, Guisheng, Zheng, Xianzhi, Wang, Jianming, Lu, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228392/
https://www.ncbi.nlm.nih.gov/pubmed/28105221
http://dx.doi.org/10.3892/ol.2016.5351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228392/
https://www.ncbi.nlm.nih.gov/pubmed/28105221
http://dx.doi.org/10.3892/ol.2016.5351

Ejemplares similares